Findings on Drug Development Reported by Investigators at York University (The Interdependent Influence of Lobbying and Intellectual Capital On New Drug Development)
Prof. Vareska van der Vrande, Dr Patricia Klopf, and the Research Software Engineering and Consulting (RSEC) team at RSM are listed as funders for this article on pharmaceutical firms' resource allocation decision toward lobbying…
Outlet:
NewsRX Drugs and Therapies
Media Type:
Online
Monday, 4 March 2024